title: [Sleep apnea and cardiac pacing: mechanisms of action and perspectives].
abstract: In an adult population, the prevalence of sleep apnea is 4% for men and 2% for women. Generally, nasal positive pressure ventilation is the best therapeutic option. To date, and in spite of the possible presence of marked brady-arrhythmias during sleep apnea, there is no recognised indication for Pacemaker implantation. However, recent data show the potential benefit of permanent cardiac stimulation in these patients. Increasing heart rate (using atrial pacing) improves cardiac output, and reduces pulmonary congestion and pulmonary vagal afferent nerves are no longer stimulated. The incidence of central sleep apnea is thereby reduced. Excessive nocturnal vagal tone increases snoring and sleep apnea, because of excessive relaxation of the oropharyngeal muscles. In patients with bradycardia, atrial stimulation may oppose increased vagal tone, by stimulating the sympathetic system or maintaining it at a minimal level. It is therefore possible that cardiac stimulation will become part of the treatment of sleep apnea in patients with documented bradycardia and/or heart failure.
authors: Hôpital cardiologique du Haut-Lévêque, 19, avenue de Magellan, 33600 Bordeaux-Pessac, France. stephane.garrigue@chu-bordeaux.fr
authors: S
authors: S
authors: Garrigue
authors: P
authors: P
authors: Bordier
authors: J
authors: J
authors: Clémenty
mesh_terms: D002304:Cardiac Pacing, Artificial; D006801:Humans; D012891:Sleep Apnea Syndromes / Q000150:complications / Q000628:therapy*